𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic Determinants of Coxsackievirus B3 Pathogenesis

✍ Scribed by BRUCE M. McMANUS; BOBBY YANAGAWA; NANA REZAI; HONGLIN LUO; LYDIA TAYLOR; MARY ZHANG; JANE YUAN; JONATHAN BUCKLEY; TIMOTHY TRICHE; GEORGE SCHREINER; DECHENG YANG


Book ID
111397889
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
84 KB
Volume
975
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Molecular epidemiology of Coxsackievirus
✍ Pei-Yu Chu; Guan-Ming Ke; Yao-Shen Chen; Po-Liang Lu; Hsiu-Lin Chen; Min-Sheng L 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 706 KB
Comparative analysis of two coxsackievir
✍ Dr. H.-C. Selinka; A. Wolde; A. Pasch; K. Klingel; J.-J. Schnorr; J.-H. Küpper; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB

## Abstract Strain‐specific differences in the interaction of coxsackievirus B3 (CVB3) with the coxsackievirus‐adenovirus receptor (CAR) and the decay‐accelerating factor (DAF) co‐receptor proteins were investigated using a non‐haemagglutinating (CVB3) and a haemagglutinating (CVB3‐HA) strain of CV

The viral genetic background determines
✍ M. Schmidtke; I. Merkle; K. Klingel; E. Hammerschmidt; A.E. Zautner; P. Wutzler 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB

## Abstract The reasons for the different outcome of coxsackievirus B3 (CVB3)‐induced heart disease in humans are not well understood. Since there are no experimental data on the course of disease after infection with genetically different CVB3 in a natural variable population until now, we studied

Molecular determinants of disease in cox
✍ Javier O. Cifuente; María F. Ferrer; Carolina Jaquenod de Giusti; Wen-Chao Song; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 788 KB

## Abstract To understand better how different genomic regions may confer pathogenicity for the coxsackievirus B (CVB), two intratypic CVB1 variants, and a number of recombinant viruses were studied. Sequencing analysis showed 23 nucleotide changes between the parental non‐pathogenic CVB1N and the